Skip to main navigation
Skip to search
Skip to main content
Help & FAQ
Home
Profiles
Research Units
Equipment
Projects
Research Output
Prizes
Activities
Press / Media
Search by expertise, name or affiliation
A Phase 2, Open-label Trial of guadecitabine (SGI-110) in patients with T-cell Lymphoma
Shortt, Jake
(Primary Chief Investigator (PCI))
Medicine Monash Health
Project
:
Research
Overview
Project Details
Project Description
NMA HREC Reference Number: HREC/17/MonH/555
Monash Health Ref: 17-0000-631A
Status
Active
Effective start/end date
3/06/19
→
2/06/24
View all
View less
Keywords
clinical trial
treatment efficacy
T-cell lymphoma